
A new study explores immune reconstitution inflammatory syndrome (IRIS) in non-HIV patients and its similarities with immune-related adverse events (irAEs) from checkpoint inhibitors. While some immunological markers overlap, differences in Tregs, cytokines, and herpesvirus DNA suggest these conditions are distinct. Findings highlight potential biomarkers but no definitive diagnostic cut-offs yet.
Like
Save
Share